2023
DOI: 10.1016/j.jaip.2023.05.046
|View full text |Cite
|
Sign up to set email alerts
|

Chronic or recurrent Campylobacter enteritis in primary immunodeficiency: A UK national case-series and review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 32 publications
1
2
0
Order By: Relevance
“…Poor adherence to treatment and gastrointestinal protein loss probably contributed to the inadequate IgG levels. Decreased T cell levels have also been observed previously [ 14 , 19 ], suggesting the presence of T cell dysfunction in CVID patients. The patient’s immunodeficiency and the use of concomitant immunosuppression may also contribute to T cell depletion, increasing susceptibility to infection.…”
Section: Discussionsupporting
confidence: 72%
See 2 more Smart Citations
“…Poor adherence to treatment and gastrointestinal protein loss probably contributed to the inadequate IgG levels. Decreased T cell levels have also been observed previously [ 14 , 19 ], suggesting the presence of T cell dysfunction in CVID patients. The patient’s immunodeficiency and the use of concomitant immunosuppression may also contribute to T cell depletion, increasing susceptibility to infection.…”
Section: Discussionsupporting
confidence: 72%
“…Such immunocompromised patients are more likely to develop severe complications after C. jejuni infection, to suffer from a chronic carrier status, or to have recurrent symptomatic episodes over years [ 13 ]. To date, the available literature is mainly limited to individual reports or series of CVID patients suffering from chronic or recurrent C. jejuni infection and/or complications such as bacteremia [ 9 , 15 , 16 , 17 , 18 , 19 ]. However, a cohort study of CVID patients with Campylobacter infection has recently been published [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation